DJ Biogen Inc. Stock Outperforms Competitors Despite Losses On The Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ sank 0.07% to $157.90 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.35% to 5,969.34 and the Dow Jones Industrial Average rising 0.97% to 44,296.51.
The stock's fall snapped a two-day winning streak.
Biogen Inc. closed $110.40 short of its 52-week high ($268.30), which the company achieved on January 3rd.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ fell 0.21% to $155.17 and Pfizer Inc. $(PFE)$ rose 2.07% to $25.65.
Trading volume (1.7 M) eclipsed its 50-day average volume of 1.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled November 22, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
November 22, 2024 17:07 ET (22:07 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments